1. Introduction
Constipation is a common functional gastrointestinal disorder with a high global prevalence and is associated with reduced quality of life and an increased risk of systemic diseases [
1,
2,
3,
4,
5]. Delayed intestinal transit is frequently accompanied by alterations in gut microbiota composition and impairment of epithelial barrier integrity [
6]. These changes in the intestinal microenvironment may influence neural, immune, and metabolic signaling pathways [
7]. Collectively, these observations support the concept that constipation represents not merely a clinical symptom but a pathophysiological process that affects intestinal homeostasis.
In addition to lifestyle modifications, pharmacologic agents are widely used for the management of constipation, among which sennoside is a commonly prescribed stimulant laxative [
8]. Sennoside is metabolically activated by colonic microbiota into active metabolites, including rheinanthrone, thereby enhancing intestinal motility [
9,
10]. However, prolonged exposure has been reported to alter epithelial architecture and disrupt mucosal homeostasis [
11,
12,
13]. Despite these observations, the molecular mechanisms by which changes in the luminal environment induce adaptive epithelial responses remain insufficiently characterized.
The intestinal epithelium functions not only as a passive barrier but also as a dynamic sensory interface capable of detecting mechanical and chemical stimuli within the lumen and transducing through defined molecular pathways. Transient receptor potential (TRP) channels serve as key mechanosensitive regulators of gastrointestinal sensory functions [
14]. Similarly, mechanosensitive ion channels, such as Piezo proteins, convert mechanical forces into intracellular signaling cascades that modulate epithelial behavior [
15,
16]. Furthermore, adhesion complexes organized around E-cadherin undergo mechanoregulated remodeling and contribute to the maintenance of epithelial polarity and barrier integrity [
16,
17,
18]. Together, these mechanotransductive and adhesion-associated pathways may mediate adaptive epithelial responses to alterations in the local mechanical environment. In this study, epithelial mechanoadaptation is defined as the process by which epithelial cells sense sustained mechanical cues and adjust their structural and functional properties in response to such stimulation.
However, it remains unclear how improvements in bowel motility, accompanied by changes in luminal mechanical and physical forces, influence epithelial mechanosensitive signaling and junctional organization.
Therefore, in this study, we employed sennoside administration as a model of enhanced luminal mechanical stimulation and performed a comprehensive morphological and molecular characterization of intestinal epithelial cells. By examining TRP channel-mediated mechanosensitivity, E-cadherin-associated junctional remodeling, and dynamic changes in epithelial barrier function, we sought to elucidate the molecular basis of epithelial adaptation underlying functional improvement of intestinal physiology.
3. Discussion
In the present study, our findings suggest that intestinal epithelial cells may be involved in local changes in gastrointestinal function through mechanosensitive signaling (mechanotransduction) and remodeling of cell–cell adhesions. Traditionally, the effects of stimulant laxatives have been interpreted primarily in terms of enteric neural activation and smooth muscle contraction. Previous studies have shown that sennoside stimulates colonic motility mainly via activation of enteric neurons and prostaglandin E2-mediated smooth muscle contraction [
7,
8,
24]. This classical mechanism is primarily based on metabolite-dependent activation of neuromuscular pathways. In the present study, we focused on epithelial responses associated with TRPV4 induction, E-cadherin-associated junctional remodeling, and adaptive barrier regulation under mechanical stimulation. Thus, our findings do not replace the established prostaglandin E2-mediated laxative mechanism, but suggest that epithelial mechanoadaptation may be associated with sennoside-induced changes in bowel function.
In this study, we combined in vivo and in vitro analyses to identify the induction of TRP family channels under stimulatory conditions, together with structural and functional changes in epithelial adhesion and barrier properties mediated by E-cadherin. Consistent with previous reports demonstrating that TRP channels, including TRPV4, function as mechanosensors in the gastrointestinal tract and are activated in response to membrane stretch, osmotic stress, and cytoskeleton-associated mechanical cues [
14,
22,
23], our findings suggest that epithelial mechanotransduction may be linked to regional motor responses. Furthermore, alterations in E-cadherin-mediated adhesion have been implicated in epithelial barrier remodeling under inflammatory or mechanical stress conditions [
16,
17,
18], supporting the concept that epithelial plasticity modulates intestinal physiology.
Notably, in our experimental model, sennoside administration selectively increased stool water content and distal colonic motility without affecting food intake or body weight. Although earlier studies emphasized secretory mechanisms and altered fluid transport in laxative-induced stool softening [
9,
25], our data indicate that region-specific alterations in distal colonic motor control also contribute to increased fecal water content. Increased fecal water content was evident as early as day 7 and temporally and spatially coincided with enhanced spontaneous contractions and cholinergic sensitivity in the rectum. These findings suggest that sennoside-associated changes in fecal properties may not be explained solely by osmotic effects on luminal contents but may also involve region-specific changes in distal colonic motor control.
3.1. Activation of Epithelial Mechanosensitive Ion Channels
TRP channels are multimodal sensors that convert thermal, mechanical, osmotic, and chemical stimuli into electrochemical signals and are widely expressed in gastrointestinal epithelia and neurons [
14,
22,
26]. Among these channels, TRPV4 responds to membrane stretch, osmotic changes, and physiological temperature ranges (approximately 27–35 °C) and has been implicated in epithelial barrier homeostasis and intestinal mechanosensitivity [
14,
22,
26,
27]. Clinically, excessive TRPV4 expression in the colon correlates with constipation severity [
20]. In this context, induction of TRPV4 in the distal colon and the accompanying enhancement of rectal motility observed in this study are consistent with the possibility that epithelial TRPV4-associated mechanotransduction is linked to sennoside-induced changes in distal colonic function [
14,
22,
23].
Importantly, TRPV4 induction was not uniform throughout the colon but progressively increased toward distal segments, with the highest expression in the rectum. This spatial specificity is consistent with the anatomical and functional characteristics of the distal colon, which is exposed to greater luminal pressure and tensile stress during stool storage and expulsion. Therefore, TRP channel induction by sennoside may reflect a localized adaptive response to region-specific mechanical demands, although a pharmacologic contribution cannot be excluded. This interpretation is further supported by concordant enhancement of spontaneous motility and cholinergic responsiveness in the same distal regions.
Beyond the TRP family, mechanosensitive ion channels such as Piezo1 and Piezo2 have gained attention. Activation of Piezo1 in the intestinal epithelium regulates cell stretching, regeneration, and mucus secretion [
15,
28]. TRPV4 and Piezo channels have been implicated in cytoskeleton-associated mechanotransduction pathways [
29], suggesting that TRPV4-associated responses observed after sennoside treatment may be part of a broader mechanotransduction network related to intestinal motility.
3.2. E-Cadherin-Mediated Adhesion and Barrier Remodeling
E-cadherin is a core component of epithelial adhesion complexes and functions as a mechanosensitive molecule that regulates cell polarity, adhesion strength, and barrier integrity via the cadherin–catenin complex [
17,
18]. In the present study, sennoside administration increased E-cadherin expression and expanded its localization from the basal membrane toward the luminal surface. These changes indicate reinforcement of intercellular adhesion and epithelial polarity remodeling [
16,
18,
30], consistent with altered barrier-related properties. Correspondingly, in vitro experiments demonstrated increased TEER and augmented cell spreading, supporting the interpretation that sennoside treatment is associated with enhanced electrical and mechanical epithelial barrier properties.
A notable methodological feature of this study is the use of an inverted culture system as a simplified in vitro approach to apply sustained physical stimulation without artificial stretching. This system was not intended to reproduce the complex mechanical environment of the intestine, but rather to examine whether epithelial cells can respond to sustained physical loading under controlled conditions. In the revised experiments, gravitational loading increased Ccn1 expression, a representative YAP/TAZ-associated mechanotransduction target gene [
31,
32], supporting the interpretation that this condition elicited a mechanotransduction-associated transcriptional response. Under these conditions, TRPV4 induction was accompanied by enhanced cell adhesion, and sennoside further augmented these epithelial responses. Because actin cytoskeletal remodeling is closely linked to YAP/TAZ-mediated mechanotransduction [
32], F-actin staining was also used to evaluate cytoskeletal reorganization under sennoside-treated gravitational loading conditions. TRPV4 protein levels increased with sennoside treatment, with redistribution toward cellular protrusions and peripheral regions associated with adhesion and spreading. The appearance of finely dispersed TRPV4 clusters may reflect altered localization of TRPV4 at mechanically responsive cellular interfaces.
Consistently, Trpv4 knockdown significantly attenuated cell spreading, reduced E-cadherin expression, decreased F-actin fluorescence intensity, attenuated Ccn1 expression, and restored TEER values to control levels. These findings suggest that TRPV4 may be involved in E-cadherin–centered adhesion control and epithelial barrier homeostasis. This interpretation is supported by previous studies identifying TRPV4 as a regulator of junctional dynamics and mechanosensitive signaling, as well as reports highlighting the role of E-cadherin–based adhesion in integrating mechanical tension and barrier function [
17,
20,
27,
29].
Although reduced Muc2 expression and a trend toward fewer Ki-67-positive cells were observed, these findings should be interpreted cautiously, as they may reflect changes in mucus-related barrier function and epithelial turnover [
28,
30]. Together with the increase in E-cadherin expression and TEER, these changes may indicate epithelial remodeling associated with altered barrier-related properties [
17,
20]. However, TEER alone does not fully define epithelial barrier function, and permeability assays or tight junction protein analyses were not performed. Therefore, the TEER findings should be interpreted as increased epithelial electrical resistance rather than definitive evidence of globally enhanced barrier integrity. The decrease in
Muc2 expression further suggests that the barrier response reflects epithelial remodeling rather than uniform barrier enhancement.
Because additional tissue integrity assays, detailed inflammatory histology, and comprehensive immunological profiling were not performed, epithelial stress or early mucosal alteration cannot be excluded. Therefore, the reduced Muc2 and Ki-67 signals may be interpreted as part of epithelial remodeling under the present experimental conditions, but should not be regarded as definitive evidence of physiological adaptation. Temporary thinning of the mucosal layer may increase epithelial exposure to luminal mechanical cues and potentially facilitate TRP-mediated mechanosensing [
22,
23], consistent with dynamic regulation of epithelial function under mucosal or mechanical conditions [
30].
3.3. Epithelial–Neural–Muscular Crosstalk in the Distal Colon
The distal colon and rectum are involved in stool storage and defecation, where luminal distension and mechanical forces are likely to be increased [
33,
34]. Under such conditions, intestinal epithelial cells may sense mechanical cues and release mediators such as adenosine triphosphate and serotonin (5-hydroxytryptamine), which have been reported to influence submucosal and enteric neural circuits [
14,
23,
28,
30].
In the present study, TRPV4 induction was most evident in the distal colon and rectum, where enhanced spontaneous motility and increased cholinergic responsiveness were also observed. To assess cholinergic sensitivity more specifically, oxotremorine was used instead of carbachol. Unlike carbachol, which activates both muscarinic and nicotinic receptors, oxotremorine acts as a muscarinic receptor agonist, allowing assessment of muscarinic receptor–dependent responses associated with distal colonic motility [
35].
These findings suggest a possible association between distal epithelial mechanosensitive responses and altered colonic motor function. However, the present data do not directly demonstrate neural activation, mediator release, or causal transmission from epithelial TRPV4 signaling to smooth muscle contraction. Therefore, TRPV4-associated epithelial mechanotransduction should be interpreted as an epithelial response that accompanies enhanced distal colonic motility, rather than as direct evidence of epithelial-to-neuromuscular signaling.
Taken together, these findings support the possibility that region-specific mechanical environments may influence epithelial mechanosensitivity in the distal colon. Further studies are required to determine whether these epithelial changes contribute directly to downstream neuromuscular regulation.
3.4. Improvement of Bowel Function Through Noninflammatory Mechanisms
Sennoside is metabolized by the intestinal microbiota into active compounds such as sennidin and rheinanthrone, which are believed to mediate its classical pharmacologic effects [
9,
24]. However, the epithelial mechanisms associated with sennoside treatment remain unclear. Although rheinanthrone is an important active metabolite, the present in vitro findings showed that epithelial responses to sennoside were observed under mechanical stress conditions. These observations do not exclude the established contribution of microbial metabolites such as rheinanthrone in vivo but raise the possibility that epithelial responses to the parent compound may also be involved in the context of luminal mechanical stimulation. The relative contributions of sennoside and its metabolites should be further examined in future studies.
Although long-term use of stimulant laxatives has historically been associated with epithelial atrophy, melanosis coli, and inflammatory or oxidative mechanisms, recent systematic reviews and epidemiologic studies indicate no clear increase in colorectal cancer risk with appropriate stimulant laxative use [
11,
12,
13]. The present findings may provide a possible mechanistic perspective on this safety profile: sennoside was associated with mechanical and adhesive remodeling without provoking inflammatory responses. The absence of changes in canonical inflammatory cytokines, such as IL-1β and IL-6, supports the conclusion that sennoside occurred without overt induction of these inflammatory markers.
Conversely, multiple large-scale cohort studies have demonstrated that chronic constipation is associated with significantly reduced long-term survival (>15 years) [
4], indicating that untreated constipation is not benign. The epithelial mechanosensing–related changes observed in this study may provide a physiological perspective for understanding bowel function improvement, although their relevance to long-term constipation treatment requires further investigation.
3.5. Clinical Implications and Limitations
This study suggests that epithelial plasticity may be considered as an additional component of stimulant laxative-associated bowel function, alongside the traditional neuromuscular activation model. Based on these findings, potential future directions include therapeutic strategies targeting the TRPV4–E-cadherin axis, the development of distal colon–selective formulations, and dosing approaches that consider the temporal dynamics of epithelial responses.
However, several limitations should be acknowledged. Although additional experiments were performed to increase the robustness of the motility assays, no a priori power calculation was conducted. Therefore, the overall findings should be interpreted with appropriate caution. Although the use of healthy mice does not fully recapitulate the pathological features of chronic constipation, this model is suitable for investigating fundamental regulatory mechanisms of intestinal function. The generalizability of this mechanism should be further evaluated in other models, including opioid-induced and loperamide-induced constipation [
36,
37]. Importantly, in vivo causality between epithelial TRPV4 activation and enhanced distal colonic motility remains to be established. In addition, TRPV4 expression appeared to be localized to specific epithelial subtypes; however, precise identification of these cell populations was not achieved. Although the primary purpose of the immunofluorescence analyses was to visualize the localization patterns of E-cadherin and TRPV4, fluorescence intensity was additionally quantified to support these observations. However, complementary protein-level validation by Western blotting or quantitative proteomic analysis was not performed. Furthermore, the in vitro experiments have important limitations. CT26 cells are tumor-derived and do not fully reflect normal intestinal epithelial physiology, and the gravity-loading model based on flask inversion is a simplified approach that does not reproduce the complex biomechanical environment of the intestine. Therefore, these findings should be interpreted as supportive mechanistic evidence, and further validation using primary epithelial cells, intestinal organoids, or ex vivo tissue-based mechanical loading systems will be required. The relative contributions of sennoside and its metabolites, including rheinanthrone, should also be further examined in future studies.
4. Materials and Methods
4.1. Animals
Five-week-old male BALB/cAJcl mice were obtained from CLEA Japan Inc. (Tokyo, Japan). Animals were randomly assigned using a simple random allocation method to either a control (vehicle-treated) group or a sennoside-treated group. This study compared sennoside-treated mice with control mice; therefore, no additional control groups were included. Although the number of animals varied depending on the experimental endpoint, 8–15 animals were allocated to each experimental group at each time point. Sample sizes were determined based on prior studies and preliminary experiments evaluating intestinal motility and molecular endpoints to ensure adequate biological replication. The sample size was considered sufficient to detect biologically relevant differences based on prior experience. Because multiple region-specific and mechanistic outcomes were assessed, a formal a priori power calculation was not performed. No animals or data points were excluded from the analysis, and no predefined exclusion criteria were established. Outcome assessment was not fully blinded across all experiments. However, for the additional motility assays performed during revision, outcome assessment was conducted under blinded conditions where feasible. This study was conducted in accordance with the ARRIVE guidelines, and details of ethical approval are described in the Institutional Review Board Statement section.
Mice were maintained in a specific pathogen–free (SPF) facility at the School of Allied Health Sciences, Kitasato University, under controlled environmental conditions (23 ± 3 °C; 12 h light/dark cycle). Animals had ad libitum access to water and were fed a standard commercial diet (CE-2; CLEA Japan, Inc.). Sennoside (Alfresa Pharma Corp., Osaka, Japan), a preparation containing a mixture of sennosides A and B with a total sennoside content of 8%, was dissolved in 0.5% (w/v) carboxymethyl cellulose (CMC). The administered dose was calculated based on the actual sennoside content, and sennoside was administered once daily via oral gavage using a gastric feeding needle at a dose equivalent to 4.8 mg/kg body weight for 21 consecutive days. The dose of 4.8 mg/kg body weight was selected because it corresponds to a human equivalent dose of approximately 0.39 mg/kg based on body surface area conversion, or approximately 23 mg/day for a 60 kg adult, which is close to the upper range of the usual therapeutic dose of sennoside in adults. Administration was performed at a consistent time each day to minimize circadian variability.
Mice were housed in groups of 3–4 per standard bedding cage. Bedding was changed at least once weekly. Metabolic cages were not used. Body weight was recorded daily. Animals were monitored daily for general health status, and no adverse events were observed. Food intake and water consumption were measured per cage by weighing the remaining food and water and were expressed as the mean intake per mouse by dividing total consumption by the number of animals per cage. At the experimental endpoint, mice were euthanized by cervical dislocation, and the colon was immediately excised for downstream analyses. All experimental procedures were performed under the supervision of investigators experienced in animal handling.
4.2. Fecal Observation and Analysis
To minimize circadian variability, fecal samples were collected at approximately 10:00. The number and total weight of fecal pellets were measured and expressed per hour. Fecal water content was determined using feces collected from the rectum at the time of dissection and was calculated as the difference between wet weight and dry weight after freeze-drying. Stool consistency was evaluated using the Bristol Stool Form Scale (BSFS) [
38], a validated 7-point scoring system ranging from type 1 (hard, separate lumps) to type 7 (watery stool without solid pieces), with higher scores indicating softer stool consistency. Although originally developed for clinical assessment in humans, the scale was adapted for murine fecal evaluation based on macroscopic appearance, consistent with its application in experimental rodent studies.
4.3. Gene Expression Analysis
Total RNA was extracted from colonic tissues using TRIzol reagent (Thermo Fisher Scientific Inc., Waltham, MA, USA) according to the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized from total RNA by reverse transcription using the PrimeScript RT Reagent Kit (Takara Bio Inc., Shiga, Japan). Real-time PCR was performed using SYBR Select Master Mix (Thermo Fisher Scientific Inc.) to amplify transcripts encoding Muc1, Muc2, Muc5ac, Il1b, Il4, Il6, Il10, Tnfα, Trpv4, Trpm8, Cdh1 (E-cadherin), Ccn1 and Gapdh. Amplification was carried out using the ABI 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The thermal cycling conditions were as follows: initial denaturation at 95 °C for 10 min, followed by 40 cycles of denaturation at 95 °C for 15 s and annealing/extension at 60 °C for 1 min. A melting curve analysis was performed to confirm amplification specificity.
Relative gene expression levels were calculated using the comparative Ct (2−ΔΔCt) method and normalized to Gapdh as the internal control. Primer sequences were as follows:
Muc1: 5′-GTCTTCAGGAGCTCTGGTGG and 5′-TACCACTCCAGTCCACAGCA
Muc2: 5′-GCTGACGAGTGGTTGGTGAATG and 5′-GATGAGGTGGCAGACAGGAGAC
Muc5ac: 5′-CATGGAGGGGACCTGGAAAC and 5′-CCACATGGGGTCACACTTC
Il1β: 5′-TGGACCTTCCAGGATGAGGACA and 5′-GTTCATCTCGGAGCCTGTAGTG
Il4: 5′-ATCATCGGCATTTTGAACGAGG and 5′-ACCTTGGAAGCCCTACAGACGA
Il6: 5′-TACCACTTCACAAGTCGGAGGC and 5′-CTGCAAGTGCATCATCGTTGTTC
Il10: 5′-CGGGAAGACAATAACTGCACCC and 5′-CGGTTAGCAGTATGTTGTCCAGC
Tnfα: 5′-GGTGCCTATGTCTCAGCCTCTT and 5′-GCCATAGAACTGATGAGAGGGAG
Trpv4: 5′-TCACCGCCTACTATCAGCCACT and 5′-GAACAGGACTCCTGTGAAGAGC
Cdh1 (E-cadherin): 5′-CTACAGCATCACCGGCCAA and 5′-ACACGGCATGAGAATAGAGGATG
Gapdh: 5′-AACTTTGGCATTGTTGTGGAAGG and 5′-ACACATTGGGGGTAGGAACA
Ccn1: 5′-GTGAAGTGCGTCCTTGTGGACA and 5′- CTTGACACTGGAGCATCCTGCA
4.4. Histopathological Analysis
Excised colonic tissues were fixed for 24 h in freshly prepared 4% paraformaldehyde in phosphate-buffered saline (PBS), rinsed with PBS, and embedded in paraffin. Sections (4 μm thickness) were deparaffinized in xylene and dehydrated through graded ethanol.
For immunohistochemical staining, sections underwent heat-induced antigen retrieval in 10 mmol/L citrate buffer (pH 6.0) at 95 °C for 10 min, followed by gradual cooling to room temperature (20–25 °C). Sections were permeabilized with 0.5% Triton X-100 in PBS for 10 min at room temperature. For horseradish peroxidase (HRP)/3,3′-diaminobenzidine (DAB) detection, endogenous peroxidase activity was quenched by incubation with 3% H2O2 in PBS for 10 min at room temperature.
Sections were blocked with Protein Block (Agilent Technologies, Inc., Santa Clara, CA, USA) for 30 min at room temperature. Primary antibodies against Muc2 (Santa Cruz Biotechnology, Dallas, TX, USA; catalog no. sc-15334), Ki-67 (Abcam, Cambridge, UK; catalog no. ab15580), Trpv4 (Abcam; catalog no. ab30744), E-cadherin (R&D Systems, Inc., Minneapolis, MN, USA; catalog no. AF748) and Alexa Fluor 555 Phalloidin (Thermo Fisher Scientific Inc.; catalog no. A34055) were diluted in Antibody Diluent with Background-Reducing Components (Agilent Technologies, Inc.) and incubated overnight at 4 °C.
After washing, sections were incubated for 30 min at room temperature with appropriate antibodies: anti-rabbit IgG-Alexa Fluor 488 (Cell Signaling Technology, Inc., Danvers, MA, USA; catalog no. 4412) or anti-goat IgG-Alexa Fluor 594 (Abcam; catalog no. ab150140) for fluorescence detection. Nuclei were counterstained with DAPI (DOJINDO LABORATORIES, Kumamoto, Japan), and sections were mounted using Fluorescence Mounting Medium (Agilent Technologies, Inc.).
For HRP/DAB detection, EnVision+ System-HRP–Labeled Polymer Anti-Rabbit (Agilent Technologies, Inc.) was used as the secondary reagent, followed by nuclear counterstaining with hematoxylin. Chromogenic signals were developed using the ImmPACT DAB Substrate Kit (Vector Laboratories, Inc., Newark, CA, USA). Sections were dehydrated through graded ethanol, cleared in xylene, and mounted.
Tissue observation and image acquisition were performed using a light microscope (Olympus Corporation, Tokyo, Japan). Quantitative image analysis was performed using ImageJ software version 1.54g (National Institutes of Health, Bethesda, MD, USA).
4.5. Intestinal Motility Analysis
After euthanasia, the entire intestinal tract was excised, and the mesentery was carefully removed. Tissues were immediately immersed in physiological saline (Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan) until further processing.
Krebs buffer prewarmed to 37 °C was added to a Magnus chamber connected to a circulating heating system to maintain a constant temperature of approximately 37 °C throughout the experiment. The chamber was continuously aerated using an air pump during recordings.
Following gentle luminal rinsing, both ends of the excised intestinal segment were mounted in the Magnus apparatus under defined resting tension. The upper thread was connected to a force transducer (FD Pickup, Nihon Kohden Co., Ltd., Tokyo, Japan), and changes in contractile activity were recorded using a data acquisition system (PowerLab 2/25, ADInstruments, Lexington, KY, USA) with LabChart 8 software (ADInstruments, Bella Vista, NSW, Australia).
After stabilization of spontaneous motility, acetylcholine (ACh) (Sigma-Aldrich Co. LLC, St. Louis, MO, USA) or oxotremorine (Oxo) (Sigma-Aldrich Co. LLC) was added to achieve a final concentration of 5 μM, and contractile responses were recorded. The Krebs buffer was subsequently replaced, and tissues were washed three times with fresh prewarmed Krebs buffer.
4.6. Cell Culture and Gravity Loading
The murine colon carcinoma cell line CT26, originally obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) on 21 January 2009, was cultured in RPMI-1640 medium (FUJIFILM Wako Pure Chemical Corp., Osaka, Japan) supplemented with 10% fetal bovine serum (FBS) (Biowest, Nuaillé, France). The identity of CT26 cells was authenticated on 20 May 2024, by short tandem repeat (STR) profiling, confirming consistency with the reference profile registered in the ATCC.
After 24 h, sennoside was added to the culture medium at a final concentration of 1 μg/mL, and the cells were incubated for an additional 24 h.
To model mechanical loading, culture flasks were inverted to a 90° position at the time of sennoside addition, thereby altering the direction of gravitational force acting on adherent cells and providing a sustained physical stimulus. Although this approach does not involve active stretching, changes in gravitational load have been reported to influence cell adhesion, cytoskeletal organization, and mechanosensitive signaling pathways. Mechanical stimuli are known to regulate these processes, including activation of TRP channels and other mechanically activated ion channels [
17,
20,
22,
39]. Therefore, this simplified approach was used as an in vitro approximation of mechanical loading.
For Trpv4 knockdown, cells seeded the previous day were transfected with Trpv4-specific small interfering RNA (siRNA) (Thermo Fisher Scientific Inc.) using Lipofectamine RNAiMAX (Thermo Fisher Scientific Inc.) in serum-free Opti-MEM I medium (Thermo Fisher Scientific Inc.), according to the manufacturer’s instructions. After 48 h, knockdown efficiency was confirmed by quantitative real-time PCR (qPCR). Negative control siRNA (Thermo Fisher Scientific Inc.) was used as a control.
Cell length and adhesion area were quantified after May–Giemsa staining.
4.7. Trans-Epithelial Electrical Resistance
CT26 cells were seeded into permeable insert membranes and cultured for 24 h. Sennoside (1 μg/mL) was then added, and cells were incubated for an additional 24 h. For gravitational loading, insert plates were inverted to a 90° position for 24 h.
Electrodes were placed in the apical and basolateral compartments, and transepithelial electrical resistance (TEER) was measured using a Millicell ERS-2 Electrical Resistance System (Merck & Co., Inc., Rahway, NJ, USA). TEER values were corrected by subtracting blank insert resistance and expressed as Ω·cm2. TEER values were corrected by subtracting the resistance of blank inserts and expressed as Ω·cm2, calculated as (R_sample − R_blank) × membrane surface area (0.33 cm2 for 24-well inserts).
4.8. Statistical Analysis
Quantitative data are presented as the mean ± standard error of the mean (SEM). Statistical analyses were performed using GraphPad Prism (version 10.0; GraphPad Software, San Diego, CA, USA). Data distribution normality was assessed using the Shapiro–Wilk test. For comparisons between two groups, Welch’s t-test was used for normally distributed data, whereas the Mann–Whitney U test was applied for non-normally distributed data. For comparisons among three or more groups, one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparisons test or the Kruskal–Wallis test followed by Dunn’s multiple comparisons test was used, as appropriate based on data distribution. For experiments involving two independent variables, two-way ANOVA followed by Tukey’s multiple comparisons test was used. Multiple comparisons were adjusted using the post hoc tests described above where applicable. A p value < 0.05 was considered statistically significant. Exact n values are indicated in the corresponding figure legends.